1.Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses
Junsu CHOE ; Areum HAN ; Sun Hye SHIN ; Kyungjong LEE ; Sang-Won UM ; Hojoong KIM ; Tae Yeul KIM ; Hee Jae HUH ; Yoon-La CHOI ; Joungho HAN ; Byeong-Ho JEONG
Journal of Korean Medical Science 2023;38(47):e348-
Background:
Paradoxical responses (PR) occur more frequently in lymph node tuberculosis (LNTB) than in pulmonary tuberculosis and present difficulties in differential diagnosis of drug resistance, new infection, poor patient compliance, and adverse drug reactions. Although diagnosis of mediastinal LNTB has become much easier with the development of endosonography, limited information is available. The aim of this study was to investigate the clinical course of mediastinal LNTB and the risk factors associated with PR.
Methods:
Patients diagnosed with mediastinal LNTB via endosonography were evaluated retrospectively between October 2009 and December 2019. Multivariable logistic regression was applied to evaluate the risk factors associated with PR.
Results:
Of 9,052 patients who underwent endosonography during the study period, 158 were diagnosed with mediastinal LNTB. Of these, 55 (35%) and 41 (26%) concurrently had pulmonary tuberculosis and extrapulmonary tuberculosis other than mediastinal LNTB, respectively. Of 125 patients who completed anti-tuberculosis treatment, 21 (17%) developed PR at a median of 4.4 months after initiation of anti-tuberculosis treatment. The median duration of anti-tuberculosis treatment was 6.3 and 10.4 months in patients without and with PR, respectively. Development of PR was independently associated with age < 55 years (adjusted odds ratio [aOR], 5.72; 95% confidence interval [CI], 1.81–18.14; P = 0.003), lymphocyte count < 800/μL (aOR, 8.59; 95% CI, 1.60–46.20; P = 0.012), and short axis diameter of the largest lymph node (LN) ≥ 16 mm (aOR, 5.22; 95% CI, 1.70–16.00; P = 0.004) at the time of diagnosis of mediastinal LNTB.
Conclusion
As PR occurred in one of six patients with mediastinal LNTB during antituberculosis treatment, physicians should pay attention to patients with risk factors (younger age, lymphocytopenia, and larger LN) at the time of diagnosis.
2.Duration of Treatment Effect of Extracorporeal Shock Wave on Spasticity and Subgroup-Analysis According to Number of Shocks and Application Site: A Meta-Analysis
Jae Ho OH ; Hee Dong PARK ; Seung Hee HAN ; Ga Yang SHIM ; Kyung Yeul CHOI
Annals of Rehabilitation Medicine 2019;43(2):163-177
OBJECTIVE: To investigate duration of the treatment effect of extracorporeal shockwave therapy (ESWT) on spasticity levels measured with Modified Ashworth Scale (MAS) regardless of the patient group (stroke, multiple sclerosis, and cerebral palsy) and evaluate its spasticity-reducing effect depending on the number of shocks and site of application. METHODS: PubMed, EMBASE, the Cochrane Library, and Scopus were searched from database inception to February 2018. Randomized controlled trials and cross-over trials were included. All participants had spasticity regardless of cause. ESWT was the main intervention and MAS score was the primary outcome. Among 122 screened articles, 9 trials met the inclusion criteria.
Ankle Joint
;
Cross-Over Studies
;
Elbow
;
Fingers
;
Humans
;
Multiple Sclerosis
;
Muscle Spasticity
;
Shock
;
Wrist
3.Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients.
Se Hoon LEE ; Boram LEE ; Joon Ho SHIM ; Kwang Woo LEE ; Jae Won YUN ; Sook Young KIM ; Tae You KIM ; Yeul Hong KIM ; Young Hyeh KO ; Hyun Cheol CHUNG ; Chang Sik YU ; Jeeyun LEE ; Sun Young RHA ; Tae Won KIM ; Kyung Hae JUNG ; Seock Ah IM ; Hyeong Gon MOON ; Sukki CHO ; Jin Hyoung KANG ; Jihun KIM ; Sang Kyum KIM ; Han Suk RYU ; Sang Yun HA ; Jong Il KIM ; Yeun Jun CHUNG ; Cheolmin KIM ; Hyung Lae KIM ; Woong Yang PARK ; Dong Young NOH ; Keunchil PARK
Cancer Research and Treatment 2019;51(1):211-222
PURPOSE: With the emergence of next-generation sequencing (NGS) technology, profiling a wide range of genomic alterations has become a possibility resulting in improved implementation of targeted cancer therapy. In Asian populations, the prevalence and spectrum of clinically actionable genetic alterations has not yet been determined because of a lack of studies examining high-throughput cancer genomic data. MATERIALS AND METHODS: To address this issue, 1,071 tumor samples were collected from five major cancer institutes in Korea and analyzed using targeted NGS at a centralized laboratory. Samples were either fresh frozen or formalin-fixed, paraffin embedded (FFPE) and the quality and yield of extracted genomic DNA was assessed. In order to estimate the effect of sample condition on the quality of sequencing results, tissue preparation method, specimen type (resected or biopsied) and tissue storage time were compared. RESULTS: We detected 7,360 non-synonymous point mutations, 1,164 small insertions and deletions, 3,173 copy number alterations, and 462 structural variants. Fifty-four percent of tumors had one or more clinically relevant genetic mutation. The distribution of actionable variants was variable among different genes. Fresh frozen tissues, surgically resected specimens, and recently obtained specimens generated superior sequencing results over FFPE tissues, biopsied specimens, and tissues with long storage duration. CONCLUSION: In order to overcome, challenges involved in bringing NGS testing into routine clinical use, a centralized laboratory model was designed that could improve the NGS workflows, provide appropriate turnaround times and control costs with goal of enabling precision medicine.
Academies and Institutes
;
Asian Continental Ancestry Group
;
DNA
;
Humans
;
Korea
;
Methods
;
Paraffin
;
Point Mutation
;
Precision Medicine
;
Prevalence
4.Symposium: “Oncology Leadership in Asia”.
Dong Young NOH ; Jae Kyung ROH ; Yeul Hong KIM ; Kazuhiro YOSHIDA ; Hideo BABA ; Marie Cherry Lynn SAMSON-FERNANDO ; Sanjeev MISRA ; Zeba AZIZ ; Rainy UMBAS ; Yogendra P SINGH ; Tony SHU KAM MOK ; Han Kwang YANG ; Hideyuki AKAZA
Cancer Research and Treatment 2017;49(2):283-291
The symposium on “Oncology Leadership in Asia” was held as part of the official program of the 42nd Annual Meeting of the Korean Cancer Association with International Cancer Conference. Given the increasing incidence of cancer in all countries and regions of Asia, regardless of developmental stage, and also in light of the recognized need for Asian countries to enhance collaboration in cancer prevention, research, treatment and follow-up, the symposium was held with the aim of bringing together oncology specialists from eight countries and regions in Asia to present the status in their own national context and discuss the key challenges and requirements in order to establish a greater Asian presence in the area of cancer control and research. The task of bringing together diverse countries and regions is made all the more urgent in that while Asia now accounts for more than half of all new cancer cases globally, clinical guidelines are based predominantly on practices adopted in Western countries, which may not be optimized for unique ethnic, pharmacogenomic and cultural characteristics in Asia. Recognizing the need for Asia to better gather information and data for the compilation of Asia-specific clinical guidelines, the participants discussed the current status in Asia in the national and regional contexts and identified future steps towards integrated and collaborative initiatives in Asia. A key outcome of the symposium was a proposal to combine and integrate the activities of existing pan-Asian societies, including the Asian Pacific Federation of Organizations for Cancer Research and Control (APFOCC) and Asian Clinical Oncology Society (ACOS). Further proposals included the expansion of pan-Asian society membership to include individuals and the essential need to encourage the participation of young researchers in order to ensure self-sustainability of cancer control efforts in the future.
Asia
;
Asian Continental Ancestry Group
;
Cooperative Behavior
;
Cultural Characteristics
;
Follow-Up Studies
;
Humans
;
Incidence
;
Leadership*
;
Medical Oncology
;
Specialization
5.STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance.
Yoon Jung KIM ; Young KANG ; Hye Yeon PARK ; Jae Ran LEE ; Dae Yeul YU ; Takuya MURATA ; Yoichi GONDO ; Jung Hwan HWANG ; Yong Hoon KIM ; Chul Ho LEE ; Myungchull RHEE ; Pyung Lim HAN ; Bong Hyun CHUNG ; Hyun Jun LEE ; Kyoung Shim KIM
Experimental & Molecular Medicine 2016;48(2):e212-
Striatal-enriched protein tyrosine phosphatase (STEP) is abundantly expressed in the striatum, which strongly expresses dopamine and opioid receptors and mediates the effects of many drugs of abuse. However, little is known about the role of STEP in opioid receptor function. In the present study, we generated STEP-targeted mice carrying a nonsense mutation (C230X) in the kinase interaction domain of STEP by screening the N-ethyl-N-nitrosourea (ENU)-driven mutant mouse genomic DNA library and subsequent in vitro fertilization. It was confirmed that the C230X nonsense mutation completely abolished functional STEP protein expression in the brain. STEP(C230X−/−) mice showed attenuated acute morphine-induced psychomotor activity and withdrawal symptoms, whereas morphine-induced analgesia, tolerance and reward behaviors were unaffected. STEP(C230X−/−) mice displayed reduced hyperlocomotion in response to intrastriatal injection of the μ-opioid receptor agonist DAMGO, but the behavioral responses to δ- and κ-opioid receptor agonists remained intact. These results suggest that STEP has a key role in the regulation of psychomotor action and physical dependency to morphine. These data suggest that STEP inhibition may be a critical target for the treatment of withdrawal symptoms associated with morphine.
Analgesia*
;
Animals
;
Brain
;
Codon, Nonsense
;
Dopamine
;
Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
;
Ethylnitrosourea
;
Fertilization in Vitro
;
Gene Library
;
Mass Screening
;
Mice
;
Morphine*
;
Phosphotransferases
;
Protein Tyrosine Phosphatases
;
Receptors, Opioid
;
Reward*
;
Street Drugs
;
Substance Withdrawal Syndrome*
6.A Case of Emphysematous Gastritis in a Patient with End-stage Renal Disease.
Geun Jun KO ; Koung Suk PARK ; Tae Woon PARK ; Meung Yeul WOO ; Ki Jun HAN ; Sang Cheul LEE ; Jae Hee CHO
The Korean Journal of Gastroenterology 2011;58(1):38-41
Emphysematous gastritis is a rare infection of the stomach wall with high mortality rate. It is caused by gas forming organisms and may arise by local spread through the mucosa or hematogenous dissemination from distant focus. Clinical manifestation includes acute abdomen with systemic toxicity, and diagnosis is based on radiologic demonstration of gas within the gastric wall. Treatment should be aimed to cover gram-negative organisms and anaerobes using wide-spectrum intravenous antibiotics, and sometimes surgical management may be needed in order to enhance survival. Herein, we report a case of emphysematous gastritis in a patient with end stage renal disease on hemodialysis.
Anti-Bacterial Agents/therapeutic use
;
Emphysema
;
Female
;
Gastritis/complications/*diagnosis/radiography
;
Gastroscopy
;
Humans
;
Kidney Failure, Chronic/complications/*diagnosis
;
Klebsiella pneumoniae/isolation & purification
;
Middle Aged
;
Renal Dialysis
;
Sputum/microbiology
;
Tomography, X-Ray Computed
7.A Case of Membranous Glomerulonephritis in a Patient with HIV Infection.
Jae Seok KIM ; Jae Won YANG ; Min Soo KIM ; Seung Tae HAN ; Bi Ro KIM ; Hyo yeul KIM ; Byoung Geun HAN ; Seung Ok CHOI
Korean Journal of Nephrology 2007;26(6):740-743
Viral infections can be causative in many glomerular disease, and human immunodeficiency virus (HIV) infection is closely related to a collapsing focal segmental glomerulosclerosis (FSGS). This is known as HIV associated nephropathy (HIVAN) and is characterized clinically by proteinuria, often of sudden onset, with rapidly progressive renal dysfunction resulting in end stage renal disease (ESRD) over several months. Increasingly, other primary renal diseases are being described in HIV infected patients, including IgA nephropathy, an immune complex lupus-like neprhopathy, and tubulonephritis. We observed rare HIVAN case presenting membranous glomerulonephritis with nephrotic syndrome in a woman who was positive for HIV without hepatitis B viral infection. She was treated with Methylprednisolone 60 mg/day, zidovudine 600 mg/day, efavirenz 60 mg/day, and lamivudine 300 mg/day for 5 months. After treatment, proteinuria decreased from 4,092 mg/day to 419 mg/day and CD4 T cell count rose from 594/mL to 1,176/mL. The effectiveness and safety of corticosteroids in the treatment of HIVAN remained controversial but this case showed good response for steroid with triple antiviral therapy about HIVAN especially membranous glomerulonephritis.
Adrenal Cortex Hormones
;
AIDS-Associated Nephropathy
;
Antigen-Antibody Complex
;
Cell Count
;
Female
;
Glomerulonephritis, IGA
;
Glomerulonephritis, Membranous*
;
Glomerulosclerosis, Focal Segmental
;
Hepatitis B
;
HIV Infections*
;
HIV*
;
Humans
;
Kidney Failure, Chronic
;
Lamivudine
;
Methylprednisolone
;
Nephrotic Syndrome
;
Proteinuria
;
Zidovudine
8.Microsatellite Alterations in Serum DNA of Lung Cancer Patients.
Sang Cheul OH ; Young Do YOO ; So Young YOON ; Seok Jin KIM ; Jae Hong SEO ; Kwang Taek KIM ; Sang Won SHIN ; Yo Han KIM ; Yeul Hong KIM ; Jun Suk KIM
Cancer Research and Treatment 2003;35(4):289-293
No abstract available.
DNA*
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Microsatellite Repeats*
9.Plexogenic Pulmonary Arteriopathy in Congenital Heart Disease: A Report of Two Cases.
Seung Yeon HA ; Kook Yang PARK ; Hyun Yee CHO ; Young Ha OH ; Jae Gul CHUNG ; Dong Hae CHUNG ; Chung Yeul KIM ; Han Kyeom KIM
Korean Journal of Pathology 2002;36(6):412-415
Hypertensive pulmonary vascular disease can develop in those cases of congenital cardiac shunt in which critical levels of pulmonary artery pressure and flow are reached and exceeded. We have experienced two cases of plexogenic arteriopathy in complex congenital heart disease and tried to evaluate of distribution of arterial lesions by total mapping of the explanted lung. Case 1 and 2 were 12-year-old boy and 36 year-old man. They were treated with combined heart-lung transplantation. Mapping of the both lungs was done, and graded according to Heath and Edward's grading scheme. The elastic pulmonary artery was tortuous, dilated and aortic configuration. Both lungs showed mostly grade 3. Plexiform lesion or veinlike branches of hypertrophied muscular arteries arosed in a lateral branch of a muscular artery that might be proximal to an area of occlusion. Comprising the right and left lung, the right was more severe than the left. By getting closer to the distal part, the grade tended to increase to 4 to 5. By analyzing the pulmonary lobe, severe pulmonary hypertension of grade 4 or 5 was comparatively disseminated throughout the right lung. On the other hand, in the left lung, the grade of the lower lobe was higher than that of the upper lobe, and within the upper lobe, there was a tendency for the grade of inferior segment to be higher than that of the corresponding apical segment.
Adult
;
Arteries
;
Child
;
Hand
;
Heart Defects, Congenital*
;
Heart-Lung Transplantation
;
Humans
;
Hypertension
;
Hypertension, Pulmonary
;
Lung
;
Male
;
Pulmonary Artery
;
Vascular Diseases
10.The healing effect of rhGM - CSF on uninfected wounds.
Seung Kyu HAN ; Byung Soo KIM ; Ae Ree KIM ; Jae Hong SEO ; Chul Won CHOI ; Sang Won SHIN ; Yeul Hong KIM ; Woo Kyung KIM ; Jun Suk KIM
Immune Network 2001;1(1):32-35
BACKGROUND: rhGM-CSF has been shown to enhance the migration and proliferation of endothelial cells and to promote keratinocyte growth. This study was tried to evaluate the effect of rhGM-CSF dressing on the uninfected wounds. METHODS: Thirty Sprague-dawley white mice(250-300g) were selected in this study . The number of wound with the diameter of 5 mm, was 3 in left and 3 in right at the symmetric sites, respectively . The site of rhGM-CSF dressing was decided by a randomization. rhGM-CSF(Leucogen (r)) was diluted in the distilled water(5 micro gram/mL). The experimental wound group was dressed by l mL of distilled water mixed with rhGM-CSF and control wound group was dressed by l mL of distilled water. The dressing was done, every 24 hours. The criteria of comparison were the duration of wound healing duration, histologic findings and the bacterial culture of wound sites. RESULTS: The duration of wound healing was 10.3+/-1.7 days in experimental group and 10.2+/-2.8 days in control group, without significant difference. There was no specific difference of histologic findings between both groups. The pathogen was not found, at all. CONCLUSION: It seems to be that rhGM-CSF has no prominent effect on the uninfected wound healing in the mice without immune suppression.
Animals
;
Bandages
;
Endothelial Cells
;
Keratinocytes
;
Mice
;
Random Allocation
;
Rats, Sprague-Dawley
;
Water
;
Wound Healing
;
Wounds and Injuries*

Result Analysis
Print
Save
E-mail